Monday July 16, 2018
Home India India takes H...

India takes Humanity to another Level and Releases 11 Pakistani Prisoners

0
//
114
rehabilitation of 11 Pakistani prisoners
The rehabilitation of 11 Pakistani prisoners to Pakistan indicates India’s sky scrapping opinions about humanitarianism. VOA
Republish
Reprint
  • The release gain significance as it occurred just a day after a meeting of Indian PM Modi and Nawaz Sharif in Astana at SCO summit
  • This is the first India’s kind gesture towards Pakistan after the Kulbhushan Jadhav’s case
  • Each year, many Indian and Pakistani citizens are captured along the border

New Delhi, June 12, 2017: Amidst the high India-Pakistan tensions, India has released 11 Pakistani prisoners on June 12, who had served out their sentences and were sent to Pakistan through the Attari- Wagah border.

Despite the fact that Pakistan has been continuously violating ceasefire along the LoC, this rehabilitation of Pakistani prisoners to Pakistan indicates India’s sky scrapping opinions about humanitarianism.

India and Pakistan ties have always been like that of two contraries. In January, India suffered a devastating attack in Pathankot on its air force base. It blamed the Jaish-e-Mohammed (JeM), a Pakistan-based militant group led by Maulana Masood Azhar for it. All the chaos was put on a halt in August 2015.

ALSO READ: Reform of Colonial-Era Laws Aims to Bring Pakistan’s ‘Black Hole’ into the Light

Corresponding to Pakistan’s allegation against former Indian Naval officer Kulbhushan Jadhav of being involved in seditious and spying activities, India requested the ICJ for a stay on the execution. However, the tensions between both the countries augmented when the ICJ gave its verdict in India’s favour, mentioned ANI report.

Previously on March 1, India had freed 39 Pakistani prisoners as a gesture of retaliation as Pakistan too released India’s 218 prisoners.According to the list which was handed over to the Indian government on 1 January 2015, there were 476 fishermen and 50 civil servants who were imprisoned by the Pakistan custody.

This list of the people captured of one nation by the other was exchanged through diplomatic channels in January 2015. The exchange of the list took place in Islamabad and New Delhi after mutual consent on an ‘Agreement on Consular Access between India and Pakistan’ in 2008.

This agreement includes regular meeting of both the parties in which they reflect on the matters of the repatriation of all prisoners and providing them with consular access.
Apart from this, Indian Government continuously has been monitoring the status of all captured Indians in Pakistani jails.

Also, a committee, ‘India-Pakistan Judicial Committee on Prisoners’ has been constituted comprising of the retired and experienced judges belonging to the higher strata of the judiciary structure of both countries. They will ensure the proper carrying out of all the activities such as release of prisoners and humane treatment, and thus, maintaining the very humanitarian essence in the conduct.

– prepared by Himanshi Goyal of Newsgram. Twitter: @himanshi1104

Click here for reuse options!
Copyright 2017 NewsGram

Next Story

Cepheid to Establish Manufacturing Unit for TB Diagnostics in India

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment

0
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.
The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach. (IANS)

Expanding its footprint in India, US-based molecular diagnostics company Cepheid Inc on Thursday announced its plans to establish a manufacturing unit in the country to improve Tuberculosis (TB) diagnostics.

Cepheid’s GeneXpert MTB/RIF test is a closed-cartridge-based system that is easy to operate by minimally trained staff and gives results in approximately two hours, speeding the conventional backlog that used to exist in traditional diagnostic methods.

The new manufacturing unit would produce MTB/RIF test cartridges, contribute to the government’s “Make in India” initiative and thus bringing the company’s global expertise in TB diagnostics to India, the company said in a statement.

As part of the plan, Cepheid also unveiled its latest portable, easy-to-use TB-testing system — the GeneXpert Edge — which is expected to be available in India later this year, the company said.

The GeneXpert Edge is developed specifically for near-patient testing, to help support a one visit test-and-treat approach.

“Cepheid recognises the need for technological advancement and is committed to contributing significantly to India’s goal of TB eradication,” said Peter Farrell, Executive Vice President, Worldwide Commercial Operations, Cepheid.

Cepheid's Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB)
Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB).

“We are hopeful that GeneXpert Edge will help eliminate delays in TB diagnostics by providing definitive results within hours and facilitating fast and easy last-mile delivery even in the remote villages of India,” he added.

India has nearly one-fourth of the global TB patients and an estimated 4.8 lakh lives are lost every year due to delayed diagnosis and inadequate treatment and there are above 2.5 million new cases of TB every year. The country aims to eradicate TB by 2025.

Approved by the World Health Organisation (WHO) in 2010, more than 1,200 Cepheid’s GeneXpert Systems have been installed in the last two years at various Revised National Tuberculosis Control Programme (RNTCP) sites in the country and more than 2.5 million cartridges were supplied last year at various centres of Central TB Division (CTD).

Also Read: Fruit Bats Identified As Source Of Nipah Virus Outbreak in Kerala

Cepheid’s Xpert MTB/RIF test has the potential to detect Mycobacterium tuberculosis(MTB) and rifampicin-resistance mutations, which are markers for MDR-TB strains in under two hours.

Rifampicin is a drug commonly used in treating TB bacteria in first line of treatment.

Xpert MTB/RIF tests also have excellent negative predictive value, which allows clinicians to manage TB-negative patients more effectively to prevent unnecessary and costly respiratory isolations. (IANS)